|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/232 | |
| A61P 27/02 |
| (11) | Number of the document | 2819667 |
| (13) | Kind of document | T |
| (96) | European patent application number | 13760943.4 |
| Date of filing the European patent application | 2013-03-01 | |
| (97) | Date of publication of the European application | 2015-01-07 |
| (45) | Date of publication and mention of the grant of the patent | 2019-12-25 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/CA2013/050155 |
| Date | 2013-03-01 |
| (87) | Number | WO 2013/134867 |
| Date | 2013-09-19 |
| (30) | Number | Date | Country code |
| 201261605729 P | 2012-03-01 | US | |
| 201261642212 P | 2012-05-03 | US | |
| 201261644360 P | 2012-05-08 | US |
| (72) |
CADDEN, Suzanne, CA
|
| (73) |
Retinagenix Therapeutics, Inc.,
421 Kipling Street, Palo Alto, California 94301,
US
|
| (54) | RETINAL DERIVATIVES FOR USE IN IMPROVING VISUAL FUNCTION |
| RETINAL DERIVATIVES FOR USE IN IMPROVING VISUAL FUNCTION |